Lantus
Drug timelines are a Plus or Pro feature.
135 regulatory and trial events tracked for Lantus, covering 2006-07-06 to 2026-03-05. Get the full timeline:
Most recent: EMA Authorised: Lantus (insulin glargine) — sanofi-aventis Deutschland GmbH